COVID Westward Migration Continues
Key Points: In today’s Recommendation for Industry, we take a look at the latest statistics on COVID and expectations for the next few months. Read
Key Points: In today’s Recommendation for Industry, we take a look at the latest statistics on COVID and expectations for the next few months. Read
Key Points: In today’s Recommendation for Industry, we provide updates on COVID-19 and Monkeypox. Read more below. Pfizer’s Omicron-Targeting COVID-19 Vaccines Generate Stronger Immune Response.
Key Points: In today’s Recommendation for Industry, we discuss the encouraging trajectory of COVID based on TAG’s matrix and CDC’s mapping. Read more below. Women
Key Points: In today’s Recommendation for Industry, we discuss the low risk of monkeypox in the US, and what businesses can do to keep it
Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna
Key Points: In today’s Recommendation for Industry, we discuss the westward movement of COVID and increase of BA.4 and BA. 5 in the U.S. Read
Key Points: In today’s Recommendation for Industry, we discuss defending against infectious disease. Read more below. COVID-19 vaccine during pregnancy may protect infants. The COVID-19
Key Points: In today’s Recommendation for Industry, we discuss how cases seem to be improving and moving across the country, as shown through the CDC
Key Points: In today’s Recommendation for Industry, we discuss COVID masking and the Hepatitis A outbreak. Read more below. Vaccines lower risk of long COVID
Key Points: In today’s Recommendations for Industry, we discuss COVID-19 trends stabilizing and declining. Read more below. The CDC released research done on post-COVID conditions